Fumaric Acid

Fumaric Acid

SCHEMBL4562985

N#CN=C1N(CCCN2CCCCC2)CCN1CCCN1CCCCC1.O=C(O)C=CC(=O)O.O=C(O)C=CC(=O)O

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 known ✓ Q9Y5N1 7/20 0.49
HRH1 known ✓ P35367 1/20 0.38
HRH4 Q9H3N8 1/20 0.44
CYP1A2 P05177 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
BLM P54132 1/20 0.39
MAPT P10636 3/20 0.38
ACHE P22303 2/20 0.37
TSHR P16473 1/20 0.36
HDAC1 Q13547 1/20 0.36
ALDH1A1 P00352 2/20 0.36
ALOX15 P16050 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL4562984 1.00 HRH3 (0.49) HRH3HRH4CYP1A2MAPK1SMN1; SMN2
SCHEMBL13787354 0.87 HRH3 (0.57) HRH3MAPTHRH1
SCHEMBL4544208 0.83 HRH3 (0.54) HRH3CYP1A2MAPK1SMN1; SMN2MAPT
SCHEMBL4544206 0.83 HRH3 (0.54) HRH3CYP1A2MAPK1SMN1; SMN2MAPT
Fumaric Acid SCHEMBL4544051 0.78 HRH3 (0.45) HRH3HRH1ACHE
Fumaric Acid SCHEMBL4384167 0.69 HRH3 (0.59) HRH3HRH4CYP1A2TSHR
Fumaric Acid SCHEMBL4384166 0.69 HRH3 (0.59) HRH3HRH4CYP1A2TSHR
Maleic Acid SCHEMBL27441586 0.69 CYP1A2 (0.53) HRH3HRH4CYP1A2MAPK1SMN1; SMN2
SCHEMBL4395380 0.66 HRH3 (1.00) HRH3CYP1A2MAPK1SMN1; SMN2MAPT
SCHEMBL4394477 0.66 HRH3 (1.00) HRH3CYP1A2MAPK1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090181948-A1 DIAMINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-07-16 US disclosed
EP-1847530-A1 DIAMINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181948-A1 DIAMINE DERIVATIVE ARG1, PRMT5, PRMT1 HRH3 452/4885HRH1 547/4885HRH4 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.